Lenskart IPO Listing Price Prediction: GMP Crashes 95% From Peak One Day Ahead Of Listing

Lenskart IPO Listing Price Prediction, GMP: Just a day before the market debut of shares of Lenskart Solutions Ltd, the grey market premium (GMP), has plunged 95 per cent from the peak to Rs 5. According to market observers, shares of Lenskart Solutions, an eyewear retailer, are expected to see a muted listing at Rs 407 per share, with a premium of 1.24 per cent.

GMP of Lenskart Solutions’ unlisted shares went to a record high at Rs 95 on the subscription opening day on October 31.

It is important to note that the GMP is based on market sentiments and keeps changing. ‘Grey market premium’ indicates investors’ readiness to pay more than the issue price.

The Lenskart Solutions IPO received a massive response from investors, getting subscribed 28.26 times overall by the end of November 4, 2025. The Qualified Institutional Buyers (QIBs) category saw the strongest demand, booked 40.35 times, led by strong participation from foreign and domestic institutions as well as mutual funds. The Non-Institutional Investor (NII) segment was subscribed 18.23 times, with high-net-worth individuals (HNIs) applying 21.81 times their quota and small NIIs subscribing 11.06 times.

Retail investors also showed strong interest, bidding 7.54 times their allotted portion, while the employee quota was subscribed 4.96 times. Overall, the IPO attracted bids for over 281 crore shares against 9.97 crore shares on offer, reflecting strong market confidence in Lenskart’s growth story ahead of its listing.

The listing of Lenskart Solutions IPO will happen on Monday, November 10, on both the BSE and

the NSE. The allotment of unlisted shares was finalised on Thursday, November 06.

The IPO was opened on October 31 and closed on November 4.

The company has fixed the price band at Rs 382-402 per share for its IPO. At the upper end of the price band, Lenskart is seeking a valuation of around $7.91 billion (about Rs 72,700 crore).

The issue includes a fresh issue of shares worth Rs 2,150 crore, while the offer-for-sale (OFS) segment will see promoters and investors offloading more than 12.75 crore equity shares.

Option 1: Via Registrar’s Website (Link Intime India)

• Visit the Link Intime India IPO allotment page:https://www.linkintime.co.in/IPO/public-issues.html
• Select “Lenskart Solutions Limited – IPO” from the drop-down list.
• Choose one of the three identification options:
• PAN (Permanent Account Number)
• Application Number
• DP/Client ID (for demat account holders)
• Enter the chosen details correctly.
• Fill in the captcha code as shown on the screen.
• Click on “Submit” or “Search.”
• The screen will display your allotment status — showing whether you’ve been allotted shares and the quantity.

Option 2: Via BSE Website

• Visit the BSE IPO allotment page:https://www.bseindia.com/investors/appli_check.aspx
• Under “Issue Type,” select “Equity.”
• Under “Issue Name,” choose “Lenskart Solutions Limited.”
• Enter your Application Number and PAN.
• Complete the security captcha.
• Click on “Search.”
• Your allotment status will appear on the screen.

Option 3: Through Your Broker or Demat App

• Log in to your broker app (like Zerodha, Groww, Upstox, or Angel One).
• Go to the IPO section → “My Applications.”
• You’ll see the allotment status once it’s updated by the registrar.

About Lenskart

Founded in 2010, Lenskart began as an online eyewear retailer and has since grown into one of India’s leading omnichannel eyewear brands with both online and offline presence. The company was valued at $6.1 billion as of September 2025, according to Tracxn data cited by Reuters.

In June 2025, the company transitioned into a public limited entity, changing its name from Lenskart Solutions Private Limited to Lenskart Solutions Limited after an extraordinary general meeting held on May 30.

Disclaimer: The views and investment tips by experts in this News18.com report are their own and not those of the website or its management. Users are advised to check with certified experts before taking any investment decisions.